Biocept (NASDAQ:BIOC) announces the availability of 10,000 nasopharyngeal specimen collection kits for RT-PCR testing for COVID-19 for physician ordering.
Collected specimens will be shipped overnight to
Biocept’s CLIA-certified and BSL-2 safety level laboratory in San Diego
with results returned in an estimated 24 to 48 hours.
Biocept-developed RT-PCR COVID-19 kits are expected to be available in Q3.
https://seekingalpha.com/news/3584868-biocepts-covidminus-19-testing-kit-now-available-for-physician-ordering
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.